Moreover, 147 decreased plasma cTnI and creatinine, which are biomarkers of cardiac and kidney damage, respectively, and it improved behavioral indicators of post-ischemic neurological damage (Fig. 8i–k). The gene discussed is TNNI3; the disease is Nephropathy.